Raj Mehra - 31 Mar 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
President, Chief Executive Officer and Chairman of the Board of Directors, Director
Signature
/s/ Raj Mehra
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
+$56,840
Form type
4
Filing time
31 Mar 2022, 16:34:22 UTC
Previous filing
11 Jan 2022
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Purchase $56,840 +66,667 +2.1% $0.8526 3,281,546 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Remarks:

President, Chief Executive Officer and Chairman of the Board of Directors